Yuta Ando

Integrated BioTherapeutics (United States)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation”.

CCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation

Journal of Controlled Release(2020)10.1016/j.jconrel.2020.09.054

N/A

0DataRank · unranked

41 citations

Leng‐Ying Chen, Ailin Zhang, Chun‐Peng Liao, Christopher Poon, Jonathan Wang +8 more

Non-invasive Optical Biomarkers Distinguish and Track the Metabolic Status of Single Hematopoietic Stem Cells

iScience(2020)10.1016/j.isci.2020.100831

N/A

0DataRank · unranked

13 citations

Lisa Nguyen, Cosimo Arnesano, Yuta Ando, Manmeet H. Raval, Joseph T. Rodgers +4 more

Engineered in vitro tumor models for cell-based immunotherapy

Acta Biomaterialia(2021)10.1016/j.actbio.2021.03.076

N/A

0DataRank · unranked

37 citations

Chelsea F. Mariano, K. Robert Shen, Yuta Ando

Engineering a Vascularized Hypoxic Tumor Model for Therapeutic Assessment

Cells(2021)10.3390/cells10092201

N/A

0DataRank · unranked

23 citations

Jeong Min Oh, Winfield Zhao, Madeleine Tran, K. Robert Shen, Yuta Ando